Wells Fargo analyst Tiago Fauth sets a price target of $18 for NASDAQ:WVE, suggesting a potential 75$21 to $18 following updates on AATD data for the 200 and 400 cohort.Wave Life Sciences' stock fluctuated between$7.49 and $8.20 today, with a trading volume of 3,322,679 shares.Wave Life Sciences (NASDAQ:WVE) is a biotechnology company focused on developing innovative therapies for genetic diseases. The company aims to address unmet medical needs through its prop ...